Literature DB >> 25381336

Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran Lipid and Glucose Study.

Farhad Hosseinpanah1, Maryam Barzin2, Mohammadhassan Mirbolouk2, Hayedeh Abtahi2, Leyla Cheraghi2, Fereidoun Azizi3.   

Abstract

BACKGROUND: The lipid accumulation product (LAP) is a relatively new marker for measuring cardiovascular disease (CVD) risk factors. We investigated predictability of LAP value for incident CVD among Tehranian adults with normal BMI.
METHODS: A population based cohort of subjects without history of prevalent cardiovascular disease, aged ≥30 years who had BMI <25 were followed for a median (interquartile range 25-75) of 10.1 (7.25-10.57) years. Subjects were stratified according to LAP tertiles. LAP was defined as WC-58 × TG for women and WC-65 × TG for men (where WC is waist circumference and TG is triglycerides). Cox regression analyses were used to estimate the hazard ratio (HR) of CVD events; c-statistics test was also calculated to compare LAP with other anthropometric indices. RESULT: In this prospective study of 2378 subjects (57.0% men) with mean age of 46.1 ± 13.5 years, and mean BMI 22.59 ± 1.9 kg/m(2) an increasing trend of cardiovascular risk factors along LAP tertiles (except for smoking and history of premature CVD events) was observed. During follow-up 160 CVD cases occurred (incidence rates (per 1000 person-years) of CVD across LAP tertiles were 4.14 (2.88-5.96), 6.82 (5.13-9.04) and 12.37 (9.97-15.34), respectively). Adjusted HRs for development of cardiovascular disease across LAP tertiles were 1.56 (95% confidence interval (CI) =0.91-2.69) and 2.17 (95% CI = 1.22-3.86) respectively. C-statistics of LAP were not significantly higher than other anthropometric measures for predicting incident CVD.
CONCLUSION: LAP is an independent predictor of cardiovascular events in normal BMI subjects, but is not superior over other anthropometrics indices. © The European Society of Cardiology 2014.

Entities:  

Keywords:  Cardiovascular disease; body mass index; lipid accumulation product; metabolic syndrome X; metabolically obese normal weight; obesity; triglycerides

Mesh:

Year:  2014        PMID: 25381336     DOI: 10.1177/2047487314558771

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  21 in total

1.  Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?

Authors:  Nebojsa Kavaric; Aleksandra Klisic; Ana Ninic
Journal:  J Clin Lab Anal       Date:  2017-06-20       Impact factor: 2.352

2.  Lipid accumulation product and metabolic syndrome: a population-based study in northern Iran, Amol.

Authors:  N Motamed; S Razmjou; G Hemmasi; M Maadi; F Zamani
Journal:  J Endocrinol Invest       Date:  2015-08-29       Impact factor: 4.256

3.  Children's Lipid Accumulation Product Combining Visceral Adiposity Index is a Novel Indicator for Predicting Unhealthy Metabolic Phenotype Among Chinese Children and Adolescents.

Authors:  Yangyang Dong; Ling Bai; Rongrong Cai; Jinyu Zhou; Wenqing Ding
Journal:  Diabetes Metab Syndr Obes       Date:  2021-11-23       Impact factor: 3.168

4.  Comparison of anthro-metabolic indicators for predicting the risk of metabolic syndrome in the elderly population: Bushehr Elderly Health (BEH) program.

Authors:  Neda Rabiei; Ramin Heshmat; Safoora Gharibzadeh; Afshin Ostovar; Vahid Maleki; Mehdi Sadeghian; Saba Maleki Birjandi; Iraj Nabipour; Gita Shafiee; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2021-08-28

5.  Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults.

Authors:  Haijiang Dai; Weijun Wang; Ruifang Chen; Zhiheng Chen; Yao Lu; Hong Yuan
Journal:  Nutr Metab (Lond)       Date:  2017-08-01       Impact factor: 4.169

6.  Visceral adiposity index, lipid accumulation product and intracranial atherosclerotic stenosis in middle-aged and elderly Chinese.

Authors:  Rui Li; Qi Li; Min Cui; Zegang Ying; Lin Li; Tingting Zhong; Yingchao Huo; Peng Xie
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

7.  Anthropometric and central obesity indices as predictors of long-term cardiometabolic risk among Saudi young and middle-aged men and women.

Authors:  Mahmoud M A Abulmeaty; Ali M Almajwal; Najwa K Almadani; Mona S Aldosari; Ahmed A Alnajim; Saeed B Ali; Heba M Hassan; Hany A Elkatawy
Journal:  Saudi Med J       Date:  2017-04       Impact factor: 1.484

8.  The effect of lipid accumulation product and its interaction with other factors on hypertension risk in Chinese Han population: A cross-sectional study.

Authors:  Jian Song; Yingying Zhao; Sumei Nie; Xue Chen; Xuesen Wu; Jing Mi
Journal:  PLoS One       Date:  2018-06-06       Impact factor: 3.240

9.  Urine Glucose Excretion Attenuates the Association Between Lipid Accumulation Product and Serum Uric Acid in Subjects with Prediabetes.

Authors:  Juan Chen; Yu Liu; Haijian Guo; Bei Wang; Zilin Sun; Jiangyi Yu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-30       Impact factor: 3.168

10.  Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China.

Authors:  Haoyu Wang; Yingxian Sun; Zhao Li; Xiaofan Guo; Shuang Chen; Ning Ye; Yichen Tian; Lijun Zhang
Journal:  BMC Cardiovasc Disord       Date:  2018-04-10       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.